Chinese medicinal herbs in relieving perimenopausal depression: A randomized, controlled trial

Journal of Alternative and Complementary Medicine

Volumn 15, Issue 1, 2009, Pages 93-100

  Qu, Fan ^a   Cai, Xuefen ^a   Gu, Yinger ^a   Zhou, Jue ^b   Zhang, Runju ^a   Burrows, Elizabeth ^c   Huang, Hefeng ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c LONG ISLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; GENGNIANLE; HERBACEOUS AGENT; LUTEINIZING HORMONE; TIBOLONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHINESE; CHINESE MEDICINE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HAMILTON SCALE; HERB; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT DURATION;

ADULT; ANGIOSPERMS; CHINA; DEPRESSION; DRUGS, CHINESE HERBAL; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; MIDDLE AGED; NORPREGNENES; ORGANOTHERAPY; PERIMENOPAUSE; PHYTOTHERAPY;

EID: 58849165260     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2008.0267     Document Type: Article

References (79)

1. Schmidt PJ. Mood, depression, and reproductive hormones in the menopausal transition. Am J Med 2005;118:54-58.
2. Maartens LW, Leusink GL, Knottnerus JA, et al. Climacteric complaints in the community. Fam Pract 2001;18:189-194.
3. Avis NE, Brambilla D, McKinlay SM, Vass K. A longitudinal analysis of the association between menopause and depression: Results from the Massachusetts Women's Health Study. Ann Epidemiol 1994;4:214-220.
4. Zhao G, Bao Y, Qu C. Occurrence of depression symptoms and their influence factors in perimenopausal women [in Chinese]. Chin J Obstetr Gynec 1996;31:614-616.
5. Schmidt PJ, Haq N, Rubinow DR. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry 2004;161:2238-2244.
6. Freeman EW, Sammel MD, Liu L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004;61:62-70.
7. Schmidt PJ, Murphy JH, Haq N, et al. Stressful life events, personal losses, and perimenopause-related depression. Arch Womens Ment Health 2004;7:19-26.
8. Cohen L, Soares C, Vitonis A, et al. Risk for new onset of depression during the menopausal transition: The Harvard study of moods and cycles. Arch Gen Psychiatry 2006;63:385-390.
9. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006;63:375-382.
10. Woods NF, Mariella A, Mitchell ES. Patterns of depressed mood across the menopausal transition: Approaches to studying patterns in longitudinal data. Acta Obstet Gynecol Scan 2002;81:623-632.
11. Cassem NH, Papakostas GI, Fava M, Stern TA. Mood-disordered patients. In: Stern T, Fricchione G, Cassem NH, eds. Massachusetts General Hospital Handbook of General Hospital Psychiatry. Philadelphia: Mosby, 2004:69-92.
12. Joffe H, Soares CN, Cohen LS. Assessment and treatment of hot flushes and menopausal mood disturbance. Psychiatr Clin North Am 2003;26:563-580.
13. Worthington JJ, Peters PM. Treatment of antidepressant-induced sexual dysfunction. Drugs Today (Barc) 2003;39:887-896.
14. Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Maturitas 2007;56:54-60.
15. Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. Estrogen augmentation of antidepressants in perimenopausal depression: A pilot study. J Clin Psychiatry 2005;66:774-780.
16. Rasgon NL, Altshuler LL, Fairbanks LA, et al. Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women. J Clin Psychiatry 2002;63:45-48.
17. Soares CN, Poitras JR, Prouty J, et al. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms. J Clin Psychiatry 2003;64:473-479.
18. Joffe H, Groninger H, Soares CN, et al. An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy. J Womens Health Gend Based Med. 2001;10:999-1004.
19. Amsterdam J, Garcia-Espana F, Fawcett J, et al. Fluoxetine efficacy in menopausal women with and without estrogen replacement. J Affect Disord 1999;55:11-17.
20. Nagata H, Nozaki M, Nakano H. Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies. J Obstet Gynaecol Res 2005;31:107-114.
21. Murakami S, Shirota T, Hayashi S, Ishizuka B. Aromatherapy for outpatients with menopausal symptoms in obstetrics and gynecology. J Altern Complement Med 2005;11:491-494.
22. Lai JN, Hwang JS, Chen HJ, Wang JD. Finished herbal product as an alternative treatment for menopausal symptoms in climacteric women. J Altern Complement Med 2005;11:1075-1084.
23. Smolinski D, Wollner D, Orlowski J, et al. A pilot study to examine a combination botanical for the treatment of menopausal symptoms. J Altern Complement Med 2005;11:483-489.
24. Yao SA. Review on the research and development of Chinese medicine in menopausal syndrome [in Chinese]. J Tradit Chin Med 1994;35:112-114.
25. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: A review of randomized, controlled trials. Ann Intern Med 2002;137:805-813.
26. Wiseman N, ed. English-Chinese Chinese-English Dictionary of Chinese Medicine. Changsha: Hunan Science and Technology Press, 2006.
27. Notelovitz M. Postmenopausal tibolone therapy: Biologic principles and applied clinical practice. MedGenMed 2007;9:2. Online document at www.medscape.com/viewarticle/548593 Accessed November 8, 2008.
28. Robb-Nicholson C. What's the latest on tibolone, the estrogen alternative? Online document at www.health.harvard.edu/newsweek/Whats-the- latest-on-tibolone.htm Accessed November 7, 2008.
29. Baksu A, Ayas B, Citak S, et al. Efficacy of tibolone and transdermal estrogen therapy on psychological symptoms in women following surgical menopause. Int J Gynaecol Obstet 2005;91:58-62.
30. Kloosterboer HJ. Tibolone: A steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 2001;76:231-238.
31. Davis SR. The effects of tibolone on mood and libido. Menopause 2002;9:162-170.
32. Genazzani AR, Petraglia F, Facchinetti F, et al. Effects of Org OD 14 on pituitary and peripheral endorphin in castrated rats and in postmenopausal women. Maturitas 1987;1:35-48.
33. Kenemans P, Speroff L, International Tibolone Consensus Group. Tibolone: Clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. Maturitas 2005;51:21-28.
34. Egarter C, Huber J, Leikermoser R, et al. Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints. Maturitas 1996;23:55-62.
35. Huber J, Palacios S, Berglund L, et al. The effect of tibolone compared with conjugated equine oestrogens continuously combined with medroxyprogesterone acetate on bleeding rates, quality of life and tolerability in postmenopausal women. Br J Obstet Gynaecol 2002;109:886-893.
36. Roux C, Pelissier C, Fechtenbaum J, et al. Randomized, double-blind, 2-year comparison of tibolone with 17-estradiol and norethindrone acetate in preventing postmenopausal bone loss. Osteoporosis Int 2002;13:241-248.
37. Lundström E, Christow A, Svane G, et al. Effects of tibolone and a continuous combined HRT regimen on mammographic breast density. Am J Obstet Gynecol 2002;186:717-722.
38. Valdivia I, Campodonico I, Tapia A, et al. Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women. Fertil Steril 2004;81:617-623.
39. Conner P, Christow A, Kersemaekerc W. A comparative study of breast cell proliferation during hormone replacement therapy: Effect of tibolone and continuous combined estrogen progestogen therapy. Climacteric 2004;7:50-58.
40. Dören M, Rübig A, Coelingh Bennink HJT, Holzgreve W. Impact on uterine bleeding and endometrial thickness: Tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy. Menopause 1999;6:299-306.
41. Völker W, Coelingh Bennink HJT, Helmond FA. Effects of tibolone on the endometrium. Climacteric 2001;4:203-208.
42. Wender MC, Edelweiss MI, Campos LS, et al. Endometrial assessment in women using tibolone or placebo: 1-year randomized trial and 2-year observational study. Menopause 2004;11:423-429.
43. Haenggi W, Bersinger N, Altermatt HJ, Birkhäuser MH. Comparison of transvaginal ultrasonography and endometrial biopsy in endometrial surveillance in postmenopausal hormone replacement therapy users. Maturitas 1997;27:133-143.
44. Fedele L, Bianchi S, Raffaelli R, Zanconato G. A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas. Eur J Obstet Gynecol Reprod Biol 2000;88:91-94.
45. Egarter C, Sator M, Berghammer P, Huber J. Efficacy, tolerability, and rare side effects of tibolone treatment in postmenopausal women. Int J Gynaecol Obstet 1999;64:281-286.
46. Haenggi W, Lippuner K, Jaeger P, et al. Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women. Clin Endocrinol 1998;48:691-699.
47. Meeuwsen IB, Samson MM, Duursma SA, Verhaar HJ. The effect of tibolone on fat mass, fat-free mass, and total body water in postmenopausal women. Endocrinology 2001;142:4813-4817.
48. Katz VL, Lentz GM, Lobo RA, Gershenson DM, eds. Comprehensive Gynecology. Philadelphia: Mosby Elsevier, 2007.
49. Cummings SR, Ettinger B, Delmas PD, et al. The effects of tibolone in older postmenopausal women. N Engl J Med 2008;359:697-708.
50. Kuhl H, Wiegratz I. Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications? Climacteric 2007;10:344-353.
51. Sundar SS, Gornall RJ, Kerr-Wilson R, et al. A case report of recurrent endometriosis following tibolone hormone replacement therapy. J Obstet Gynaecol 2007;27:433-434.
52. Beral V, Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-427.
53. Cao BZ, ed. Great Compendium of Chinese Ancient Medical Classics. Beijing: China Press of Traditional Chinese Medicine, 1997.
54. Chinese Materia Medica. Shanghai: Shanghai Press of Science and Technology, 1999.
55. Lei ZQ, ed. Chinese Herbal Medicine. Shanghai: Shanghai Press of Science and Technology, 1994.
56. Wang BX, ed. Modern Pharmacology and Clinical Practice of Chinese Medicine. Tianjin: Tianjin Company of Scientific and Technologic Translation, 2004.
57. Xiao PG, ed. Modern Chinese Materia Medica. Beijing: The Chemical Industry Press, 2007.
58. Saito K, Umeda S, Kawashima K, Kano Y. Effects of Sansohnin-to on pentobarbital sleep in stressed mice. Bio Pharm Bull 2000;23:76-79.
59. Shiyi L. Some basic features of the new sleep-aid tea (SAT) for the treatment of insomnia. Sleep Res Online 2000;3:49-52.
60. Choi EM, Koo SJ, Hwang JK. Immune cell stimulating activity of mucopolysaccharide isolated from yam (Dioscorea batatas). J Ethnopharmacol 2004;91:1-6.
61. Wang XM,Fu H, Liu GX. Effect of Wuzi Yanzong pill and its disassembled prescription on mitochondrial DNA deletion, respiratory chain complexes and ATP synthesis in aged rats [in Chinese]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2001;21:437-440.
62. Zhang H, Han T, Zhang L, et al. Effects of tenuifolin extracted from radix polygalae on learning and memory: A behavioral and biochemical study on aged and amnesic mice. Phytomedicine 2008;15:587-594.
63. Hao SC, Bi P, Yu K, et al. Electron microscopic studies on the effect of Frutus Ligustri Lucidi on the corticotrophs of rat hypophyses [in Chinese]. J Tianjin Normal University 1997;17:4952.
64. Peng N, Clark JT, Wei CC, Wyss JM. Estrogen depletion increases blood pressure and hypothalamic norepinephrine in middle-aged spontaneously hypertensive rats. Hypertension 2003;41:1164-1167.
65. Moses EL, Drevets WC, Smith C, et al. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: A PET study. Biol Psychiatry 2000;48:854-860.
66. Sherwin BB. Estrogen function in women. Endocr Rev 2003;24:133-151.
67. Wissink S, van der Burg B, Katzenellenboge NB, vad der Saag PT. Synergistic activation of the serotonin-1A receptor by nuclear factor-kappa B and estrogen. Mol Endocrinol 2001;15:543-552.
68. Sun QX. The effects of Chinese medicinal herbs on the hypothalamic-pituitary-ovarian axis: A review [in Chinese]. Li Shizhen Med Mater Med Res 2005;16:1297-1298.
69. He JQ, Tang XW, Chen HX, Xing ZQ. Study on treatment of climacteric depression with bushen tiaogan qingxin recipe [in Chinese]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004;24:889-892.
70. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296.
71. Mulsant BH, Sweet RA, Rifai AH, et al. The use of the Hamilton Rating Scale for Depression in elderly patients with cognitive impairment and physical illness. Am J Geriatr Psychiatry 1994;2:220-229.
72. Kornstein SG, Clayton AH, eds. Women's Mental Health: A Comprehensive Textbook. New York: Guilford, 2002.
73. Tam LW, Stucky V, Hanson RE, Parry BL. Prevalence of depression in menopause: A pilot study. Arch Womens Ment Health 1999;2:175-181.
74. Douma SL, Husband C, O'Donnell ME, et al. Estrogen-related mood disorders: Reproductive life cycle factors. ANS Adv Nurs Sci 2005;28:364-375.
75. Ostland H, Keller E, Hurd YL. Estrogen receptor gene expression in relation to neuropsychiatric disorders. Ann N Y Acad Sci 2003;1007:54-63.
76. Luin VN, Khlcheoskaya RI, Mcewen BS. Effects of gonadal steroids on activities of monamine oxidase and choline acetylase in rat brains. Brain Res 1975;86:273-306.
77. Lindsay R, Dempster DW, Jordan VC, eds. Estrogens and Antiestrogens. Philadelphia: Lippincott-Raven, 1997.
78. Arpels JC. The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause: A hypothesis and review of supporting data. J Reprod Med 1996;41:633-639.
79. Berek JS, ed. Berek & Novak's Gynecology. Philadelphia: Lippincott Williams & Wilkins, 2007.